SILVERCREST ASSET MANAGEMENT GROUP LLC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1232395
NEW YORK, NY
Position in ARWR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,797,495
-$3,733,419 QoQ
Shares Held
108,413
-31.7% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 65.74027100071025.ToString("F0")%
Shared 0.ToString("F0")%
None 34.25972899928975.ToString("F0")%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SILVERCREST ASSET MANAGEMENT GROUP LLC holds $95,938,613 across 21 Biotechnology names. ARWR ranks #5 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VCEL |
Vericel Corp
|
959,207 | $30,857,689 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
15,963 | $8,356,151 | |
| 3 | MIRM |
Mirum Pharmaceuticals, Inc.
|
80,991 | $7,481,948 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
16,358 | $7,304,501 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
108,413 | $6,797,495 | |
| 6 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
163,633 | $5,943,150 | |
| 7 | PTGX |
Protagonist Therapeutics, Inc
|
47,931 | $5,051,927 | |
| 8 | ZYME |
Zymeworks Inc.
|
163,649 | $4,097,770 |
All Filings in ARWR
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,797,495 | 108,413 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,530,914 | 158,622 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,414,873 | 272,974 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,426,796 | 280,177 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,564,002 | 279,749 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,273,606 | 280,511 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,356,099 | 224,889 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,957,211 | 152,259 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $4,295,662 | 150,198 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,066,915 | 100,226 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,694,496 | 100,279 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,579,729 | 100,385 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,171,877 | 85,507 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||